0 results for 'U.S. Food and Drug Administration'
Second Circuit Sets Standard for Distinguishing Opinions From Facts in Securities Fraud Cases
A discussion of the case 'Union Asset Management Holding AG v. Philip Morris International Inc. (In re Philip Morris International Inc. Securities Litigation) where the Second Circuit elucidates on distinguishing fact from opinion.5 Lawsuits and a Class Action: Drugmaker Sued in Delaware, Connecticut
Shareholders are suing a corporation that markets itself as a biopharmaceutical company using artificial intelligence to develop neurological medicines.Amazon Named in Product Liability Claim Over Eye Drops Contaminated With Rare Bacteria
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.Hogan Lovells Rebounds in 2023 With Most Profitable Year in History
The global firm brought in $2.68 billion in revenue, which translated into $2.74 million in profits per equity partner.Handdown List released on:February 7, 2024
View more book results for the query "U.S. Food and Drug Administration"
Generative AI in Health Care: Diagnosing the Legal Landscape for Dr. GenAI
This article evaluates the regulatory trends that address issues of algorithmic data bias and data privacy and security that are inherent to the deployment of GenAI systems in health care.New Jersey Joins Second Amicus Brief Filed This Week in Mifepristone Fight Before US Supreme Court
"Going backwards in time and limiting access to medication abortion is contrary to evidence-based health care," New Jersey Attorney General Matthew J. Platkin said. "I, and other attorneys general across the nation, urge the Supreme Court to reject this baseless attack on reproductive care."Plaintiff Adequately Alleges Drug Company's Scienter Over Statements About FDA Approval
Discovery Stay Motion Is Granted But Discovery's Bifurcation Is Premature
Clogged Up: Lawsuits Are Flying Against Johnson & Johnson Over Decongestant
On Sept. 12, 2023, the FDA issued a report on phenylephrine, saying that there were no safety issues found with its use as a decongestant but there were also no benefits, the suit said.Trending Stories
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now